DarioHealth (NASDAQ:DRIO) Shares Cross Below Two Hundred Day Moving Average – Here’s Why

DarioHealth Corp. (NASDAQ:DRIO) shares crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $1.22 and traded as low as $1.02. DarioHealth shares last traded at $1.06, with a volume of 84,911 shares.

DarioHealth Stock Performance

The company has a debt-to-equity ratio of 0.34, a current ratio of 2.26 and a quick ratio of 1.96. The firm has a market capitalization of $30.52 million, a P/E ratio of -0.61 and a beta of 1.48. The stock’s 50 day moving average is $0.92 and its two-hundred day moving average is $1.21.

DarioHealth (NASDAQ:DRIO) last issued its earnings results on Thursday, August 8th. The company reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.51) by $0.43. DarioHealth had a negative net margin of 265.33% and a negative return on equity of 74.64%. The firm had revenue of $6.26 million during the quarter, compared to the consensus estimate of $7.57 million. As a group, equities analysts anticipate that DarioHealth Corp. will post -1.21 earnings per share for the current fiscal year.

Institutional Investors Weigh In On DarioHealth

Large investors have recently bought and sold shares of the company. DLK Investment Management LLC increased its stake in DarioHealth by 71.6% in the third quarter. DLK Investment Management LLC now owns 100,550 shares of the company’s stock valued at $113,000 after purchasing an additional 41,943 shares in the last quarter. Clarity Capital Partners LLC bought a new stake in DarioHealth in the fourth quarter valued at approximately $293,000. Finally, Appian Way Asset Management LP increased its stake in DarioHealth by 3.1% in the second quarter. Appian Way Asset Management LP now owns 1,375,880 shares of the company’s stock valued at $1,637,000 after purchasing an additional 41,738 shares in the last quarter. Institutional investors own 33.39% of the company’s stock.

About DarioHealth

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.